K oS 1424 |
510(K) Summary
. MAR 1 9 2009
Submitter: Cynosure, Inc.
5 Carlisle Road
Westford, MA 01886

Contact: George Cho

Senior Vice President of Medical Technology
- Date Summary Prepared: May 16, 2008

Device Trade Name: Affirm CO, and Affirm CO, HP lasers

Common Name: Medical Laser System

Classification Name: Instrument, surgical, powered, laser
79-GEX
21 CFR 878.4810

Equivalent Device: Smart CO, laser and SmartXide CO, with DOT Scanner laser :

: Device Description: Affirm CO, and Affirm CO, HP lasers are CO: laser, having CO gas :
as the lasing medium. It is a laser with a wavelength of 10.6 ym.
Laser activation is by foot switch. Overall weight of the laser is 25
Kg, and the size is 180x62x42 cm (HxWxD).
Electrical requirement is 110 VAC, 15A, 50-60 Hz, single phase.

Intended Use: Affirm CO, and Affirm CO. HP lasers are indicated for incision,
excision, and coagulation of body soft tissue.

Comparison: The Affirm CO, and Affirm CO; HP lasets are substantially equivalent
to the Smart CO laser and the SmartXide CO with DOT Scanner
laser, with the same principle of operation, the same wavelength and
essentially the same power range as the predicate devices for the same
indications for uses.

Nonclinical Performance Data: none

Clinical Performance Data: none

Conclusion: The Affirm CO, and Affirm CO HP lasers are another safe and
effective device for body soft tissue applications.

Additional Information: none

7 ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
ene Food and Drug Administration
9200 Corporate Boulevard
Cynosure, Inc. Rockville MD 20850 .
% Mr. George Cho MARIS 2003
Senior Vice President of Medical Technology
5 Carlisle Road .
Westford, Massachusetts 01886
Re: K081424
Trade/Device Name: Affirm CO, and Affirm CO, HP lassers /
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and plastic surgery and in
dermatology
Regulatory Class: II
Product Code: GEX
Dated: March 13, 2009
Received: March 16, 2009
Dear Mr. Cho:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
“commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
‘You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. : ,
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to such additional controls, Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that ‘your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Mr. George Cho
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally _
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Center for Devices and Radiological Health’s (CDRH *s) Office of Compliance at
(240) 276-0115. Also, please note the regulation entitled, “Misbranding by reference to
premarket notification” (21CFR Part 807.97). For questions tegarding postmarket surveillance,
please contact CDRH’s Office of Surveillance and Biometric’s (OSB’s) Division of Postmarket  Surveillance at (240) 276-3474, For questions regarding the reporting of device adverse events
(Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems
at (240) 276-3464. You may obtain other general information on your responsibilities under the
Act from the Division of Small Manufacturers, International and Consumer Assistance _
at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address
hitp://www.fda,gov/cdrh/industry/support/index.html.
Sincerely yours, ai — .
Mark N. Melkerson
: Director
: Division of General, Restorative
and Neurological Devices .
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

|
|
510(k) Number (if known): K 08) 4a4

| Device Name: Affirm CO, and Affirm CQ HP lasers

| Indications For Use:

, The Affirm CO, and Affirm CO, HP lasers with SmartScan scanner are indicated for incision,

: . excision, ablation, vaporization, and coagulation of body soft tissue including intraoral tissues, in
medical specialties including aesthetic (dermatology and plastic surgery), otolaryngology (ENT),
gynaecology, neurosurgery, dental, and oral surgery and genitourinary surgery. The use with the
scanning unit is indicated for ablative skin resurfacing.

ao
Prescriptive Use x OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (Part 21 CFR 801 Subpart C) :
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) :
Concurrence of CDRH, Office of Device Evaluation(ODE)
e | {,,
(Division Sign-Off ;
Division of General, Restorative,
and Neurological Devices
| 510(k) Number_KO 8142-4

